TipRanks
Go Ultimate55% OFF

V2X (1V1) AI Stock Analysis

DE:1V1

V2X

(Frankfurt:1V1)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue Growth and Backlog VisibilityDouble-digit quarterly growth and substantial backlog coverage provide strong visibility into near-term revenue delivery. The backlog supports customer continuity and reduces dependence on winning all future work immediately, while raised full-year guidance indicates management sees momentum as durable.
Negative Factors
Structurally Thin Profit MarginsThin margins leave limited room for contract overruns, unfavorable mix, or execution issues to be absorbed without affecting earnings. They also make profitability more dependent on disciplined cost control and successful delivery, constraining the durability of returns even as revenue expands.

V2X (1V1) vs. iShares MSCI Germany ETF (EWG)

-20%-10%0%10%20%30%40%50%60%DE:1V1+44.40%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 2.52B
Dividend Yield
―
Average Volume (3M)
74
Price to Earnings (P/E)
27.5
Beta (1Y)
0.68
Revenue Growth
5.31%
EPS Growth
22.72%
Country
Germany
Employees
16,200
Sector
Industrials
Sector Strength
63
Industry
Aerospace & Defense

V2X Business Overview & Revenue Model

Company Description

V2X, Inc. provides critical mission solutions and support services to defense customers internationally. It offers a suite of integrated solutions multi-domain impact readiness, integrated supply chain management, mission solutions, platform renewal...

V2X Earnings Call Summary

Earnings Call Date:Aug 02, 2026(Q2-2026)|% Change Since:-6.36%|Next Earnings Date:Nov 01, 2026
Earnings Call SentimentPositive

The call conveyed solid operational momentum with double-digit revenue growth, meaningful EPS and adjusted net income gains, strengthened backlog/funded backlog, significant new awards and a large AI-enabled bid pipeline. Management raised full-year guidance and highlighted improving cash generation, net-debt reduction and a positive credit outlook. Key near-term headwinds are lumpiness in bookings, a material contraction in Kuwait/LOGCAP activity (~$150M H2), GAAP operating cash usage in H1, and modest adjusted EBITDA margins that leave room for improvement. On balance, the positive revenue, earnings, backlog and guidance revisions outweigh the execution and timing risks discussed.

Positive Updates

Strong Revenue and EPS Growth
Q2 revenue grew 17% year-over-year to $1.257 billion. Adjusted diluted EPS was $1.64, up ~23% year-over-year. Adjusted net income for the quarter was $51.6 million, up 22% year-over-year.

Negative Updates

Quarterly Bookings Weakness and Lumpiness
Bookings in Q2 were $600 million yielding a quarterly book-to-bill of 0.5x (though trailing 12-month book-to-bill was 1.4x). Management noted lumpiness and timing risk of awards, with some large awards arriving after quarter close.

Company Guidance

V2X raised full‑year guidance to revenue of $4.875–$5.025 billion, adjusted EBITDA of $347.5–$362.5 million, adjusted diluted EPS of $5.90–$6.30 and adjusted net cash from operating activities of $160–$180 million; at the midpoints management expects roughly 10% year‑over‑year growth in revenue and adjusted EBITDA and ~16% growth in adjusted diluted EPS, aims to reach net leverage of ~2x or below by year‑end, and noted that 98% of 2026 revenue is already in backlog (total backlog $12.7 billion; funded backlog $2.5 billion, up 10% sequentially and 8% YoY). Management cited supporting operating metrics from the quarter and year‑to‑date — Q2 revenue $1.257 billion (up 17% YoY), Q2 adjusted EBITDA $89.8 million (7.1% margin), Q2 adjusted diluted EPS $1.64; YTD revenue $2.511 billion (up 20% YTD) and adjusted EBITDA $175.4 million — and bookings of $600 million in the quarter (quarterly book‑to‑bill 0.5x, trailing 12‑month 1.4x; management targets ~1.3–1.5x book‑to‑bill for the year) as the basis for the upgraded guidance.

V2X Risk Analysis

V2X disclosed 49 risk factors in its most recent earnings report. V2X reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

V2X Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

DE:1V1 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
DRSDRS74Outperform$10.05B27.7013.04%0.96%8.85%37.35%
HIIHII73Outperform$12.49B17.0413.95%1.74%12.64%28.39%
AIRAIR71Outperform$4.03B20.3411.63%―21.97%515.59%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
VSECVSEC60Neutral$4.15B53.763.73%0.27%23.35%56.45%
AMTMAMTM55Neutral$5.35B26.354.44%―11.44%291.35%

* Industrials Sector Average

Performance Comparison

0%25%50%75%DE:1V1AIRHIIDRSVSECAMTMDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:1V1 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:1V1V2x, Inc.72.2023.8049.17%
AIRAAR Corp.100.2614.5316.95%
HIIHuntington Ingalls Industries316.884.531.45%
DRSLeonardo Drs, Inc.37.681.383.79%
VSECVSE Corporation147.83-32.77-18.15%
AMTMAmentum Holdings, Inc.21.87-0.33-1.49%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.